This HTML5 document contains 138 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37294887
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel bilimsel makale наукова стаття, опублікована в травні 2009 wissenschaftlicher Artikel scientific article published on 15 May 2009 artigo científico مقالة علمية نشرت في 15 مايو 2009 vedecký článok vetenskaplig artikel videnskabelig artikel article científic научни чланак article scientifique vědecký článek articolo scientifico artículu científicu espublizáu en 2009
p:P577
wds:Q37294887-42F0F111-9EC9-40AE-BEFD-4B8732433128
wdt:P577
2009-05-15T00:00:00Z
p:P407
wds:Q37294887-24EF399E-BB17-4733-895E-3BAD2F7773B1
wdt:P407
wd:Q1860
p:P2860
wds:Q37294887-94CF8B5B-B9B5-45EE-B2E4-0FB3F5E101E5 wds:Q37294887-6A478F01-87FE-4A84-A7DC-EDBA5AC03E54 wds:Q37294887-65C6A289-3E97-42FC-BA08-07629BCED5EF wds:Q37294887-68FC0B65-3B15-4DD4-812E-6E5DD8F0C4E7 wds:Q37294887-4EE1528B-4F13-4F7E-BB91-2F3441F41D70 wds:Q37294887-344386FF-6E54-4B5E-A4CB-2120E3A30F3F wds:Q37294887-3F3F7DBA-CEA9-49B3-922B-38016A8841DD wds:Q37294887-44ED7766-EA23-44BB-BE23-EFA82B822C18 wds:Q37294887-1945E62B-B82B-40F5-9C3E-27332E4CBE67 wds:Q37294887-1CACB890-1E6C-43BB-B32F-543385B111A5 wds:Q37294887-30D6AB56-8AD3-4C10-9EE2-1AF864854556 wds:Q37294887-0F0B747C-988D-4650-82BC-9BEE192E86B0 wds:Q37294887-16DC335A-441B-46A9-BB5E-A172CE52CDA0 wds:Q37294887-18762201-07E5-405C-A490-1E8F65C6935A wds:Q37294887-022536C0-0456-49D9-8E2A-A8909DC5B8D6 wds:Q37294887-0CCF5E91-E9F9-4C0F-A375-6E6D9843C049 wds:Q37294887-FDDC0181-BF21-4FD2-8FF8-3C692D586F10 wds:Q37294887-FEEDC171-900B-491C-B9F8-DA37E7F18699 wds:Q37294887-EECEA0F9-1B3C-4CC6-88BB-5598D5554D24 wds:Q37294887-FCDDCC4C-A24A-4C9B-9021-364277962574 wds:Q37294887-E96CA528-0944-4042-8043-41D0E3A7FF06 wds:Q37294887-D2C46965-A279-40CC-ACF3-1581863EE71D wds:Q37294887-B9705DB2-106B-4CD9-93B1-2AF348B57593 wds:Q37294887-C4830380-C193-4E66-B290-CC75DE3A67A2 wds:Q37294887-C4B069FE-EDA9-4D3E-BD2E-0E8E939F402F wds:Q37294887-C932E284-662A-4702-9E94-4415AD1A13BE wds:Q37294887-B28C4DB2-BF10-4B77-B399-D94911FA3FE5 wds:Q37294887-8A99F6B3-CC14-40DC-8E56-CE5C8FAF1AA0
wdt:P2860
wd:Q35927982 wd:Q36026296 wd:Q37069649 wd:Q34680152 wd:Q34260615 wd:Q36477537 wd:Q33788306 wd:Q33319552 wd:Q34975629 wd:Q47918332 wd:Q33302903 wd:Q47854795 wd:Q73224191 wd:Q80981083 wd:Q51562434 wd:Q34397061 wd:Q24658073 wd:Q47845665 wd:Q37267850 wd:Q34359432 wd:Q36019395 wd:Q80828635 wd:Q80553894 wd:Q55953067 wd:Q33356029 wd:Q36266766 wd:Q33359552 wd:Q36748243
p:P2093
wds:Q37294887-48373140-20B3-4FD0-877A-08038DF5C9CD
wdt:P2093
Laura B Martin
rdfs:label
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals.
skos:prefLabel
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals. A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals
schema:name
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals. A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals
p:P50
wds:Q37294887-09BB4649-CDBA-4A38-9F61-EA577BD3F4F6 wds:Q37294887-1745AD04-AFCA-4206-A188-8C8FCDD9C15A wds:Q37294887-E8F79611-254D-461F-9788-DD080262FA61 wds:Q37294887-528028B6-8524-4240-863F-5C04CFBE5D14 wds:Q37294887-597B7E66-0F75-48BD-B07F-925886C3CB64 wds:Q37294887-6C80F5C2-DA55-4FF2-8A01-C2DCA8EA6062 wds:Q37294887-9058B316-5D69-4A6F-BC25-941522A70065 wds:Q37294887-94CA941E-9244-410A-8852-5014D650B187 wds:Q37294887-97809C63-894F-458D-81D9-C803F2BDEC26 wds:Q37294887-A99584C5-CECE-4478-BC48-5FB727B9A092
wdt:P50
wd:Q66908908 wd:Q48691498 wd:Q1646045 wd:Q66876252 wd:Q114406017 wd:Q114406008 wd:Q37369315 wd:Q88672445 wd:Q72369361 wd:Q87882927
p:P1476
wds:Q37294887-D08674E1-3A78-49FD-B52D-E159C75B16A9
wdt:P1476
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals
p:P304
wds:Q37294887-D4075B44-64E4-4F65-8FD1-9E440820111F
wdt:P304
4104-4109
p:P31
wds:Q37294887-86559F83-2144-4C17-89D6-ECEA2BE07970
wdt:P31
wd:Q13442814
p:P921
wds:Q37294887-FF5E1833-4E7F-4E3A-A744-7A0D17E00F23 wds:Q37294887-52EFA88C-948E-411D-B435-09A3CC3184CE wds:Q37294887-F9737F90-896A-4901-A0D4-9FF431C498F0
wdt:P921
wd:Q6741353 wd:Q12156 wd:Q134808
p:P698
wds:Q37294887-5EAE32A3-F7C5-4680-9504-179CE470680E
wdtn:P698
n7:19410624
wdt:P698
19410624
p:P1433
wds:Q37294887-EF54FD98-504F-4CFA-8436-F8E6F192E6B0
wdt:P1433
wd:Q7907941
p:P433
wds:Q37294887-851F3CF7-8689-42B1-AC83-5D94D8DABD1B
p:P478
wds:Q37294887-A2E5036E-0E40-410B-A9DF-9B8FEA2A7EDB
wdt:P433
31
wdt:P478
27
p:P1104
wds:Q37294887-D3505920-7F23-4874-BEFD-62CE18221049
wdt:P1104
6
p:P356
wds:Q37294887-EEAAFD2E-1907-428E-9FCF-C890B50C1E47
wdtn:P356
n12:J.VACCINE.2009.04.077
wdt:P356
10.1016/J.VACCINE.2009.04.077
p:P5875
wds:Q37294887-E07245B5-9640-4EA8-AA3F-7B6851279D96
wdt:P5875
24397426
p:P932
wds:Q37294887-018D1B1D-A322-40A8-B573-6956E0877249
wdt:P932
2722923